AUTHORS
Mehraju D Lone, MS, PhD, Mohd Sayeed, PhD2, Praveen Kumar, MS, PhD3, Alaa Hamdy Habieb, MBBS, Msc4, Liyan Yang, PhD5, Snehal Sambare, MS6, Job Dekker, MS, PhD7, Michael Engel, MD, PhD8
AFFILIATIONS
1 University of Virginia, Charlottesville, Virginia, United States
2 University of Virginia, CHARLOTTESVILLE, Virginia, United States
3 University of Virginia, CHARLOTTESVILLE, Virginia, United States
4 University of Virginia, CHARLOTTESVILLE, Virginia, United States
5 University of Massachusetts Medical School, Worcester, Massachusetts, United States
6 University of Massachusetts Medical School, Worcester, Massachusetts, United States
7 University of Massachusetts Medical School, Worcester, Massachusetts, United States
8 University of Virginia, Charlottesville, Virginia, United States
ABSTRACT
Background
Commitment to the erythroid lineage requires coordinated remodeling of chromatin architecture and gene expression. Although LSD1 is a well-established regulator of erythropoiesis, whether it directs higher-order genome organization during lineage commitment and how this process is mechanistically coordinated remain unknown.
Methods
We integrated in situ Hi-C, ATAC-seq, RNA-seq, Activity-by-Contact (ABC) analysis, proximity-dependent proteomics, biochemical interaction studies, CRISPR-mediated gene editing, and functional differentiation assays in K562 cells and primary human CD34⁺ hematopoietic progenitors to define the role of LSD1 in erythroid genome remodeling.
Results
LSD1 depletion impaired erythroid differentiation, suppressed erythroid transcriptional programs, and altered lineage output in both K562 cells and primary CD34⁺ hematopoietic progenitors. Early Hi-C analysis demonstrated that LSD1 is dispensable for maintaining topologically associating domains but is required for differentiation-associated compartment remodeling and reinforcement of erythroid chromatin loops. Integration of chromatin conformation, chromatin accessibility, and Activity-by-Contact analyses revealed selective loss of enhancer–promoter communication at erythroid loci despite preservation of higher-order chromosomal architecture, indicating that LSD1 regulates lineage-specific chromatin interactions rather than global genome organization.
Unbiased proximity proteomics identified the ChAHP complex as a prominent LSD1-associated chromatin regulatory partner. Despite physical association, LSD1 and ChAHP exerted reciprocal biological functions: depletion of ADNP, CBX3, or CHD4 enhanced erythroid differentiation, whereas LSD1 depletion blocked erythroid maturation. Genome-wide chromatin profiling demonstrated reciprocal regulation of lineage-specific chromatin accessibility and transcription factor networks, with LSD1 promoting erythroid regulatory programs and ChAHP maintaining alternative lineage-associated chromatin states. These opposing activities were conserved in primary human CD34⁺ hematopoietic progenitors, where modulation of the LSD1–ChAHP axis altered erythroid differentiation and colony-forming potential.
Conclusions
We identify the LSD1–ChAHP axis as a molecular regulator that couples epigenetic control to three-dimensional genome organization during erythroid differentiation. Our findings support a model in which erythroid lineage commitment is driven by selective remodeling of lineage-specific chromatin interactions within a preserved architectural framework rather than wholesale reorganization of chromosome structure. These findings establish a mechanistic link between chromatin regulatory complexes and higher-order genome organization during hematopoietic lineage specification and provide a framework for understanding how genome architecture is dynamically remodeled during differentiation.
DISCLOSURES
Mehraju D Lone, MS, PhD: No relevant conflicts of interest to declare.